Loading clinical trials...
Loading clinical trials...
A Randomized, Parallel-group, Double-blind and Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Vilaprisan in Subjects With Uterine Fibroids
Conditions
Interventions
Vilaprisan (BAY1002670)
Placebo
Locations
87
United States
Clearview Medical Research, LLC
Canyon Country, California, United States
Diagnamics, Inc.
Encinitas, California, United States
National Research Institute
Huntington Park, California, United States
Grossmont Center for Clinical Research
La Mesa, California, United States
West Coast OB/GYN Associates
La Mesa, California, United States
National Research Institute
Panorama City, California, United States
Start Date
January 24, 2018
Primary Completion Date
March 23, 2019
Completion Date
June 30, 2021
Last Updated
June 30, 2022
NCT05862272
NCT07474688
NCT02100904
NCT03948789
NCT07384468
NCT07177534
Lead Sponsor
Bayer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions